Services

Professional and Cost-Saving Solutions

AI-Guided Stability & Developability Optimization

Creative Enzymes applies computational stability engineering to extend enzyme operational lifespan, reduce formulation complexity, and lower manufacturing costs. Our platform predicts and mitigates thermal inactivation, aggregation, pH sensitivity, and expression-related folding defects before experimental validation, ensuring that optimized variants are manufacturable and process-ready.

Stability Engineering Challenges

Enzyme stability under process and storage conditions is a primary determinant of commercial viability. Common developability limitations include:

Thermal Inactivation

Loss of activity at temperatures required for reaction kinetics or sterilization protocols.

Aggregation Tendency

Irreversible oligomerization or precipitation during expression, purification, concentration, or long-term storage.

pH Tolerance

Narrow operational pH range restricting buffer flexibility and process compatibility.

Folding Propensity

Low soluble yield or inclusion body formation in heterologous hosts, inflating downstream processing costs.

These challenges often originate from surface charge distribution, core packing defects, flexible loop regions, or exposed hydrophobic patches that are not apparent from sequence inspection alone. Addressing them computationally reduces the experimental burden of stabilizing variants through trial-and-error mutagenesis.

AI-Based Stability Prediction

Our platform integrates four predictive modules that map sequence and structure to stability outcomes:

Thermal Stability

Prediction of melting temperature and long-term thermal inactivation rates using ensemble models trained on experimental thermostability datasets. Features include core packing quality, loop flexibility metrics, and surface charge network analysis.

Aggregation Tendency

Assessment of colloidal and conformational stability through prediction of exposed hydrophobic surface area, charge asymmetry, and propensity for intermolecular β-sheet formation.

pH Tolerance

Modeling of titratable group distributions and electrostatic surface potential to identify pH-sensitive regions and predict optimal operational range.

Folding Propensity

Evaluation of intrinsic disorder, contact order, and predicted expression yield in standard hosts using sequence-derived folding kinetics models.

Each module generates residue-level hypotheses for stabilizing mutations, with explicit trade-off warnings when stabilization is predicted to compromise active-site dynamics or catalytic efficiency.

Optimization Workflow

AI-Guided Stability & Developability Optimization Workflow

1. Baseline Characterization: The starting enzyme is analyzed for stability liabilities using sequence-based predictors and, where available, structural models. Critical hotspots are ranked by predicted impact on process-relevant conditions.

2. Stabilizing Mutation Design: ML models propose substitutions that enhance core packing, introduce stabilizing salt bridges, reduce surface hydrophobicity, or rigidify flexible loops. Mutations are filtered to exclude positions predicted to interfere with catalytic function.

3. Variant Library Construction: Ranked mutations are synthesized as single-point and combinatorial variants, with library depth calibrated to screening capacity and project timeline.

4. Experimental Validation: Variants are expressed and subjected to accelerated stress testing: thermal shift assays, thermal inactivation time courses, aggregation kinetics under concentration stress, and pH stability profiling. Soluble yield and monomeric purity are quantified by analytical methods.

5. Iterative Refinement: Experimental results refine prediction models and inform subsequent design rounds. Typically, 2–3 cycles converge on variants with substantially improved stability profiles and retained catalytic performance.

Wet Lab Validation Support

Computational stabilization predictions require rigorous experimental confirmation under process-relevant conditions. Our validation pipeline ensures that stability gains translate to manufacturable performance:

Service Description
Thermal Characterization Differential scanning fluorimetry and thermal inactivation time courses to quantify melting temperature shifts and operational half-life at target temperatures
Aggregation Profiling Dynamic light scattering, size-exclusion chromatography, and accelerated concentration stress testing to assess colloidal stability and shelf-life projections
pH Stability Mapping Residual activity assays across the operational pH range, with identification of optimal and marginal conditions for process design
Expression and Solubility Quantification Total and soluble yield determination in standard hosts, with analytical assessment of monomeric purity and oligomeric state
Formulation Screening Systematic evaluation of buffer systems, ionic strength, and excipient combinations to maximize stability under storage and shipping conditions

Validation results feed directly into subsequent design iterations, closing the optimization loop with quantitative feedback.

Deliverables

  • Stability liability report: Identified vulnerabilities with mechanistic interpretation and predicted impact on manufacturing and storage
  • Ranked variant list: Stabilizing mutations with predicted effect magnitude, confidence scores, and structural rationale
  • Stress test data package: Thermal, pH, and aggregation characterization results under defined conditions
  • Formulation recommendation: Suggested buffer systems, excipients, and storage conditions based on variant biophysical properties

Case Study

ProteinMPNN for Enhanced Protein Stability and Expression

Design strategy for the optimization of protein expression and stability using ProteinMPNN Figure 1. Design strategy for the optimization of protein expression and stability using ProteinMPNN. (Sumida et al., 2024)

This study demonstrated how the deep learning model ProteinMPNN can improve the expression, stability, and functionality of biotechnologically important proteins. Using myoglobin and tobacco etch virus (TEV) protease as model systems, researchers combined structure-based sequence design with evolutionary constraints and AlphaFold2 structural validation. Functional residues near catalytic and substrate-binding sites were preserved to maintain activity, while redesigned regions enhanced protein properties. The engineered proteins showed improved expression levels, higher thermal stability, and enhanced functional performance. Notably, several TEV protease variants displayed greater catalytic activity than both the parent enzyme and previously reported mutants. The work highlights the potential of AI-guided protein design for optimizing native proteins for industrial and research applications.

FAQs

  • Q: Can you optimize stability without losing activity?

    A: Yes. Our filtering pipeline explicitly excludes mutations predicted to perturb active-site geometry or dynamic coupling. Multi-objective scoring balances stability gain against catalytic retention.
  • Q: What starting materials do I need?

    A: A purified enzyme, expression construct, or sequence with demonstrated activity is sufficient. Structural information accelerates the process but is not mandatory.
  • Q: How many design cycles are typically required?

    A: 2–3 cycles for moderate improvements; 4 cycles for substantial thermal upgrades or multi-property stabilization.
  • Q: Do you provide formulation recommendations?

    A: Yes. Deliverables include suggested buffer systems, pH ranges, and excipient strategies based on the biophysical profile of the optimized variant.
  • Q: Can this integrate with activity optimization?

    A: Yes. Stability-optimized variants can serve as robust scaffolds for subsequent activity engineering, or both properties can be optimized in parallel through multi-objective scoring.
  • Q: What is the typical timeline?

    A: 8–12 weeks per design-test cycle. Most projects achieve target stability within 2–3 cycles.

References:

  1. Sumida KH, Núñez-Franco R, Kalvet I, et al. Improving protein expression, stability, and function with proteinmpnn. J Am Chem Soc. 2024;146(3):2054-2061. doi:10.1021/jacs.3c10941

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services
Online Inquiry

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.